Issue
Title
Authors
No 10 (2018)
Regulatory aspects of the introduction of the drug therapy outcomes-based payment concept
Tolkushin A.G., Fedorov A.A., Yagudina R.I., Davydovskaya M.V., Chernitskaya M.K., Ermolaeva T.N., Kobzeva N.V., Kokushkin K.A.
PDF
(Rus)
No 4 (2024)
Drug insurance: modern products on the market in Russia and their development prospects
Kondrashov A.A., Kurashov M.M., Loskutova E.E.
PDF
(Rus)
No 3 (2023)
Approaches to evaluating the effectiveness of the pharmacovigilance system in the Republic of Kazakhstan
Taube A.A., 2
PDF
(Rus)
No 11 (2019)
EAEU registration procedure: opportunities for work automation
Olefir Y.V., Rychikhina E.M., Koshechkin K.A.
PDF
(Rus)
No 10 (2020)
Innovative medicines on the Russian pharmaceutical market:key players and main directions of development
Chaplenko A.A., Vlasov V.V., Gildeeva G.N.
PDF
(Rus)
No 10 (2019)
Experiment ahead of time: about the Moscow experiment on preferential drug provision
Telnova E.A.
PDF
(Rus)
No 3 (2025)
Results of the analysis of the functioning of the pharmacovigilance system of the marketing authorization holder
Taube A.A.
PDF
(Rus)
No 4 (2021)
Development of proposals for improving the processes of circulation of extemporal drugs and regulation of prescription and production activities of pharmaceutical organizations in the Russian Federation
Narkevich I.A., Golant Z.M., Yurochkin D.S., Leshkevich A.A., Erdni-Garyaev S.E.
No 10 (2018)
The importance of pharmaceutical quality system design at the drug manufacturers in the context of formation of the EAEU pharmaceutical market
Goryachkin V.V., Smirnov V.A., Shestakov V.N., Abramovich R.A., Denisova M.N.
PDF
(Rus)
No 4 (2024)
Assessment of the impact of «evergreening patients» on the budget segment of the Russian pharmaceutical market
Denisova M.N., Nadelyaeva I.I.
PDF
(Rus)
No 4 (2019)
CHALLENGES AND ISSUES IN OPERATING PERSONNEL MANAGEMENT DURING THE IMPLEMENTATION OF PHARMACEUTICAL QUALITY SYSTEM
SMIRNOV V.A., GORYACHKIN V.V., SHESTAKOV V.N., ABRAMOVICH R.A.
PDF
(Rus)
No 3 (2022)
Analysis of the budget expenditure for rare diseases in the subjects of the Russian Federation
Komarov I.A., Krasilnikova E.Y., Aleksandrova O.Y.
PDF
(Rus)
No 4 (2019)
Non-adherence as the reason for unreliable result s of a clinical study
MELIKHOV O.G., TATARENKO A.O.
PDF
(Rus)
No 2 (2022)
Peoples preferential provision of medicines, medical devices, specialized health food products: system and regulation in the Perm region
Maleeva T.L., Shilnikova S.V., Novikova N.V., Tarasevich V.N.
PDF
(Rus)
No 6 (2018)
State policy in the sphere of pharmaceutics in the USSR in the 1930s
Sherstneva E.V.
PDF
(Rus)
No 2 (2024)
The activities of public organizations to reduce inequality in the availability of medicines to the population. Part 2. Public organizations and their role in drug provision issues
Vrubel M.E.
PDF
(Rus)
No 4 (2019)
PRESCRIPTION DRUG INSURANCE: CHOOSING A PATH
Popovich L.D.
PDF
(Rus)
No 2 (2022)
The use of the Min-Max method in assessing the effectiveness of health care and drug provision of the population
Yagudina R.I., Gavrilina N.I.
PDF
(Rus)
No 6 (2018)
How much does humanity weigh?
Philippova I.
PDF
(Rus)
No 1 (2024)
Analysis of drug safety risk factors in medical organizations of Moscow in 2020 2022
Kuznetsova E.V., Zhuravleva M.V., Mikhailov I.A., Khabriev R.U.
PDF
(Rus)
No 3 (2019)
Review of Federal medicine assistance schemes
Kovaleva K.A., Narkevich I.A., Nemyatykh D., Vasyagina Y.A.
PDF
(Rus)
No 2 (2022)
“New” rare diseases and budget deficiency: is the problem “great”?
Komarov I.A., Krasilnikova E.Y., Aleksandrova O.Y.
PDF
(Rus)
No 1-2 (2018)
State regulation of prices on medicines: search for balance
Kopytin D.A.
PDF
(Rus)
No 4 (2023)
Personalized approach to drug therapy is a current direction in improving algorithms of pharmaceutical counseling
Bredikhina T.A., Popov S.S., Mikhailova E.V.
PDF
(Rus)
No 3 (2019)
Review of PIC/S guidance on classification of GMP deficiencies
Orlov V.A.
PDF
(Rus)
No 2 (2022)
Improving operational pharmacovigilance systems in the context of new geopolitical risks
Krasheninnikov A.E.
PDF
(Rus)
No 12 (2019)
International approaches to the formation of the quality system of the pharmaceutical inspectorate
Nikolenko N.S., Beregovykh V.V.
PDF
(Rus)
No 11-12 (2020)
Analysis of performance indicators of the High-cost Nosologies program in the constituent entities of the Russian Federation
Petrukhina I.K., Yagudina R.I., Ryazanova T.K., Gladunova E.P., Egorova A.V., Khusainova A.I., Blinkova P.R., Loginova L.V.
PDF
(Rus)
No 1 (2022)
Activities of municipalities in the field of drug provision of the population in Russia in the second half of the XIX - early XX century
Sherstneva E.V., Egorysheva I.V.
No 2 (2023)
Analysis of the State Pharmacopoiea’s of the Russian Federation requirements’ coverage of drug products and drug substance of different origin and drug products included in the list of vital and primary drug products
Yarutkin A.V., Bagirova V.L., Berezhnaya E.S.
PDF
(Rus)
No 1 (2022)
Rare diseases in the subjects of the Russian Federation: are these patients rare?
Komarov I.A., Krasilnikova E.Y., Aleksandrova O.Y.
No 2 (2023)
Monitoring information on the safety of antibacterial and anti-tuberculosis drugs
Egiazaryan E.A., Kosova I.V.
PDF
(Rus)
No 9 (2020)
3D printing in pharmacy
Prozherina Y.
PDF
(Rus)
No 4 (2021)
Organization of work of the staff of a pharmacy organization in the pharmacovigilance system
Kurganova E.Y., Soloninina A.V., Poskrebysheva A.S.
No 9 (2019)
Development of the rare (orphan) drug market
Yurochkin D.S., Golant Z.M., Narkevich I.A.
PDF
(Rus)
No 2 (2023)
Production of domestic drugs in the first period of the Great Patriotic War
Камельских Д.В., Серебряный Р.С.
PDF
(Rus)
No 4-6 (2020)
Overview of key launches on the Russian pharmaceutical market, 2019
Kalinina N.
PDF
(Rus)
No 1 (2025)
Transformation of the list of vital and essential medicines in 2009 2023
Denisova M.N., Sinitsyna A.A., Naneishvili E.G.
PDF
(Rus)
No 7-8 (2019)
Analysis of the drug assortment for palliative care for children in the Russian Federation
Narkevich I.A., Nemyatykh O.D., Medvedeva D.M., Vrubel E.T.
PDF
(Rus)
No 1 (2023)
Applications of some biodegradable polymers in medicine
Abbasov I.B.
PDF
(Rus)
No 1-3 (2020)
Drug product release in 2019
Romanova S.
PDF
(Rus)
No 13S (2018)
Vikram Punia: «Our key goal is to reduce dependence of the country on drug imports»
Article E.
PDF
(Rus)
No 1 (2025)
Patient-oriented model of organization of medical care provision to patients suffering from drug addiction diseases
Tsarev S.A., Suslin S.A., Bogatyreva G.P., Kashirin A.K., Izmalkov N.S., Sadreeva S.K.
PDF
(Rus)
No 5 (2019)
Nomenclature of gene-therapy drugs: international experience
Mokhov A.A., Merkulov V.A., Melnikova E.V., Popov P.I., Dudchenko V.V., Koshechkin К.А., Chaplenko A.A., Yavorsky A.N.
PDF
(Rus)
No 1 (2023)
The history of the opioid epidemic in USA
Khabibova M.R., Mezentseva E.S.
PDF
(Rus)
No 1-3 (2020)
Russian Pharmaceutical Market in 2019
Kalinina N.
PDF
(Rus)
1 - 46 of 46 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"

Mailing Address

Address: 105064, Moscow, st. Vorontsovo Pole, 12, building 1

Email: redactor@remedium-journal.ru

Phone: +7(495) 917-48-86



Principal Contact

Sherstneva Elena Vladimirovna
EXECUTIVE SECRETARY
FSSBI «N.A. Semashko National Research Institute of Public Health»

105064, Vorontsovo Pole st., 12, Moscow


Email: redactor@remedium-journal.ru

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies